While people wait for the BRR interview regarding ADO's latest feasibility agreement you may wish to read a paper Philips presented in 2009 which touches on their investigation into the POC Troponin test.
Worth reading in the light of the latest agreement with Philips whereby they have allowed ADO access to the biosensor. We were initially alerted to this opportunity on 11 June through a blog from Hangas75. It is coming up to three months since this initial exposure to the biosensor.
On 27th August we had a formal feasibility announcement and a very random linkedin photo of GC playing ten pin bowling. After nigh on three months since the first access there is an official feasibility agreement. One would expect that for ADO to sign this agreement they would already have a very good idea of the answer to the biosensor.
All IMO.
ADO Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
